{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:09:42Z","timestamp":1787850582298,"version":"build-2784847793"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s12185-020-03001-w","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T11:03:38Z","timestamp":1600859018000},"page":"106-111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Interferon therapy for pregnant patients with essential thrombocythemia in Japan"],"prefix":"10.1007","volume":"113","author":[{"given":"Yoko","family":"Edahiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soji","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Itakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-9126","authenticated-orcid":false,"given":"Norio","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"issue":"5","key":"3001_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s12185-014-1567-1","volume":"99","author":"Y Edahiro","year":"2014","unstructured":"Edahiro Y, Morishita S, Takahashi K, Hironaka Y, Yahata Y, Sunami Y, et al. JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan. Int J Hematol. 2014;99(5):625\u201334.","journal-title":"Int J Hematol"},{"issue":"2","key":"3001_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/HUMREP\/11.2.406","volume":"11","author":"NJ Ellish","year":"1996","unstructured":"Ellish NJ, Saboda K, O'Connor J, Nasca PC, Stanek EJ, Boyle C. A prospective study of early pregnancy loss. Hum Reprod. 1996;11(2):406\u201312.","journal-title":"Hum Reprod"},{"issue":"1","key":"3001_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-2006-942204","volume":"211","author":"HH Gunter","year":"2007","unstructured":"Gunter HH, Scharf A, Hillemanns P, Wenzlaff P, Maul H. Pregnancies without prenatal care\u2013which women are potentially affected, what are the inherent fetal risks? Z Geburtshilfe Neonatol. 2007;211(1):27\u2013322.","journal-title":"Z Geburtshilfe Neonatol"},{"issue":"10","key":"3001_CR4","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1111\/jog.14083","volume":"45","author":"K Morita","year":"2019","unstructured":"Morita K, Ono Y, Takeshita T, Sugi T, Fujii T, Yamada H, et al. Risk factors and outcomes of recurrent pregnancy loss in Japan. J Obstet Gynaecol Res. 2019;45(10):1997\u20132006.","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"3001_CR5","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1038\/s41598-018-22546-9","volume":"8","author":"R Haruyama","year":"2018","unstructured":"Haruyama R, Gilmour S, Ota E, Abe SK, Rahman MM, Nomura S, et al. Causes and risk factors for singleton stillbirth in Japan: analysis of a nationwide perinatal database, 2013\u20132014. Sci Rep. 2018;8(1):4117.","journal-title":"Sci Rep"},{"issue":"3","key":"3001_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/jog.13460","volume":"44","author":"S Sakata","year":"2018","unstructured":"Sakata S, Konishi S, Ng CFS, Watanabe C. Preterm birth rates in Japan from 1979 to 2014: analysis of national vital statistics. J Obstet Gynaecol Res. 2018;44(3):390\u20136.","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"3001_CR7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1600-0609.2009.01214.x","volume":"82","author":"N Gangat","year":"2009","unstructured":"Gangat N, Wolanskyj AP, Schwager S, Tefferi A. Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies. Eur J Haematol. 2009;82(5):350\u20133.","journal-title":"Eur J Haematol"},{"issue":"2","key":"3001_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1182\/blood-2007-01-071068","volume":"110","author":"F Passamonti","year":"2007","unstructured":"Passamonti F, Randi ML, Rumi E, Pungolino E, Elena C, Pietra D, et al. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation. Blood. 2007;110(2):485\u20139.","journal-title":"Blood"},{"issue":"5","key":"3001_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.blre.2008.03.007","volume":"22","author":"M Griesshammer","year":"2008","unstructured":"Griesshammer M, Struve S, Barbui T. Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy. Blood Rev. 2008;22(5):235\u201345.","journal-title":"Blood Rev"},{"issue":"10","key":"3001_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/ajh.21504","volume":"84","author":"L Melillo","year":"2009","unstructured":"Melillo L, Tieghi A, Candoni A, Radaelli F, Ciancia R, Specchia G, et al. Outcome of 122 pregnancies in essential thrombocythemia patients: a report from the Italian registry. Am J Hematol. 2009;84(10):636\u201340.","journal-title":"Am J Hematol"},{"issue":"6","key":"3001_CR11","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.ajog.2004.05.001","volume":"191","author":"P Martinelli","year":"2004","unstructured":"Martinelli P, Martinelli V, Agangi A, Maruotti GM, Paladini D, Ciancia R, et al. Interferon alfa treatment for pregnant women affected by essential thrombocythemia: case reports and a review. Am J Obstet Gynecol. 2004;191(6):2016\u201320.","journal-title":"Am J Obstet Gynecol"},{"issue":"4 Pt 2","key":"3001_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-2006-942763","volume":"32","author":"M Griesshammer","year":"2006","unstructured":"Griesshammer M, Struve S, Harrison CM. Essential thrombocythemia\/polycythemia vera and pregnancy: the need for an observational study in Europe. Semin Thromb Hemost. 2006;32(4 Pt 2):422\u20139.","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"3001_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejogrb.2011.04.040","volume":"158","author":"MC Valera","year":"2011","unstructured":"Valera MC, Parant O, Vayssiere C, Arnal JF, Payrastre B. Essential thrombocythemia and pregnancy. Eur J Obstet Gynecol Reprod Biol. 2011;158(2):141\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"3001_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1200\/JCO.2010.31.8436","volume":"29","author":"T Barbui","year":"2011","unstructured":"Barbui T, Barosi G, Birgegard G, Cervantes F, Finazzi G, Griesshammer M, et al. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet. J Clin Oncol. 2011;29(6):761\u201370.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3001_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1365-2141.2010.08122.x","volume":"149","author":"CN Harrison","year":"2010","unstructured":"Harrison CN, Bareford D, Butt N, Campbell P, Conneally E, Drummond M, et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol. 2010;149(3):352\u201375.","journal-title":"Br J Haematol"},{"key":"3001_CR16","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008."},{"issue":"12","key":"3001_CR17","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.leukres.2011.06.016","volume":"35","author":"S Morishita","year":"2011","unstructured":"Morishita S, Komatsu N, Kirito K, Koda AH, Sekiguchi Y, Tsuneda S, et al. Alternately binding probe competitive PCR as a simple, cost-effective, and accurate quantification method for JAK2V617F allele burden in myeloproliferative neoplasms. Leuk Res. 2011;35(12):1632\u20136.","journal-title":"Leuk Res"},{"issue":"8","key":"3001_CR18","doi-asserted-by":"publisher","first-page":"e104958","DOI":"10.1371\/journal.pone.0104958","volume":"9","author":"H Takei","year":"2014","unstructured":"Takei H, Morishita S, Araki M, Edahiro Y, Sunami Y, Hironaka Y, et al. Detection of MPLW515L\/K mutations and determination of allele frequencies with a single-tube PCR assay. PLoS ONE. 2014;9(8):e104958.","journal-title":"PLoS ONE"},{"issue":"2","key":"3001_CR19","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.3324\/haematol.2014.115113","volume":"100","author":"S Shirane","year":"2015","unstructured":"Shirane S, Araki M, Morishita S, Edahiro Y, Takei H, Yoo Y, et al. JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms. Haematologica. 2015;100(2):e46\u2013e4848.","journal-title":"Haematologica"},{"issue":"6","key":"3001_CR20","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s12185-018-2421-7","volume":"107","author":"K Misawa","year":"2018","unstructured":"Misawa K, Yasuda H, Araki M, Ochiai T, Morishita S, Shirane S, et al. Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms. Int J Hematol. 2018;107(6):673\u201380.","journal-title":"Int J Hematol"},{"issue":"24","key":"3001_CR21","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.2169\/internalmedicine.1311-18","volume":"57","author":"Y Edahiro","year":"2018","unstructured":"Edahiro Y, Ando J, Suzuki T, Fukumura Y, Masuda A, Sakayori S, et al. Multiple placental infarcts in a pregnant woman with essential thrombocythemia. Intern Med. 2018;57(24):3647\u201350.","journal-title":"Intern Med"},{"key":"3001_CR22","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1182\/blood-2018-99-118299","volume":"132","author":"D Maze","year":"2008","unstructured":"Maze D, Kazi S, Gupta V, Malinowski AK, Fazelzad R, Shah PS, et al. Pregnancy outcomes in patients with myeloproliferative neoplasms: a systematic review and meta-analysis. Blood. 2008;132:3046.","journal-title":"Blood"},{"issue":"5","key":"3001_CR23","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.3324\/haematol.2015.139691","volume":"101","author":"Y Beauverd","year":"2016","unstructured":"Beauverd Y, Radia D, Cargo C, Knapper S, Drummond M, Pillai A, et al. Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series. Haematologica. 2016;101(5):e182\u2013e184184.","journal-title":"Haematologica"},{"issue":"18","key":"3001_CR24","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1182\/blood.2019000428","volume":"134","author":"A Yacoub","year":"2019","unstructured":"Yacoub A, Mascarenhas J, Kosiorek H, Prchal JT, Berenzon D, Baer MR, et al. Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea. Blood. 2019;134(18):1498\u2013509.","journal-title":"Blood"},{"issue":"2","key":"3001_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12185-017-2397-8","volume":"108","author":"K Sakai","year":"2018","unstructured":"Sakai K, Ueda A, Hasegawa M, Ueda Y. Efficacy and safety of interferon alpha for essential thrombocythemia during pregnancy: two cases and a literature review. Int J Hematol. 2018;108(2):203\u20137.","journal-title":"Int J Hematol"},{"issue":"5","key":"3001_CR26","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00277-017-2946-5","volume":"96","author":"Y Yoshida","year":"2017","unstructured":"Yoshida Y, Katsurada T, Nakabou Y, Kawabata H. Efficacy of interferon-alpha in essential thrombocythemia during pregnancy. Ann Hematol. 2017;96(5):877\u20138.","journal-title":"Ann Hematol"},{"issue":"8","key":"3001_CR27","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1182\/blood-2008-03-143537","volume":"112","author":"JJ Kiladjian","year":"2008","unstructured":"Kiladjian JJ, Cassinat B, Chevret S, Turlure P, Cambier N, Roussel M, et al. Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera. Blood. 2008;112(8):3065\u201372.","journal-title":"Blood"},{"issue":"6","key":"3001_CR28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1182\/blood-2012-07-442012","volume":"122","author":"A Quintas-Cardama","year":"2013","unstructured":"Quintas-Cardama A, Abdel-Wahab O, Manshouri T, Kilpivaara O, Cortes J, Roupie AL, et al. Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon alpha-2a. Blood. 2013;122(6):893\u2013901.","journal-title":"Blood"},{"issue":"6","key":"3001_CR29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1600-0609.2004.00324.x","volume":"73","author":"R Niittyvuopio","year":"2004","unstructured":"Niittyvuopio R, Juvonen E, Kaaja R, Oksanen K, Hallman H, Timonen T, et al. Pregnancy in essential thrombocythaemia: experience with 40 pregnancies. Eur J Haematol. 2004;73(6):431\u20136.","journal-title":"Eur J Haematol"},{"issue":"3","key":"3001_CR30","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.ajog.2004.10.598","volume":"192","author":"B Norgard","year":"2005","unstructured":"Norgard B, Puho E, Czeizel AE, Skriver MV, Sorensen HT. Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case\u2013control study. Am J Obstet Gynecol. 2005;192(3):922\u20133.","journal-title":"Am J Obstet Gynecol"},{"key":"3001_CR31","volume-title":"Practical guidelines for hematological malignancies, 2018","author":"Japanese Society of Hematology","year":"2018","unstructured":"Japanese Society of Hematology. Practical guidelines for hematological malignancies, 2018. Tokyo: Kanehara Shuppan; 2018."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-03001-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-020-03001-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-03001-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:02:15Z","timestamp":1632355335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-020-03001-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["3001"],"URL":"https:\/\/doi.org\/10.1007\/s12185-020-03001-w","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"assertion":[{"value":"10 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}